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Catechol-O-methyltransferease (COMT) metabolizes prefrontal cortex dopamine (DA), a neurotransmitter involved in executive
behavior; the Val158Met genotype has been linked to executive dysfunction, which might increase sexual risk behaviors favoring
HIV transmission. Main and interaction eﬀects of COMT genotype and executive functioning on sexual risk behavior were
examined. 192 sexually active nonmonogamous men completed a sexual behavior questionnaire, executive functioning tests, and
were genotyped using blood-derived DNA. Main eﬀects for executive dysfunction but not COMT on number of sexual partners
were observed. A COMT x executive dysfunction interaction was found for number of sexual partners and insertive anal sex,
signiﬁcant for carriers of the Met/Met and to a lesser extent Val/Met genotypes but not Val/Val carriers. In the context of HIV
and methamphetamine dependence, dopaminergic overactivity in prefrontal cortex conferred by the Met/Met genotype appears
to result in a liability for executive dysfunction and potentially associated risky sexual behavior.
1.Introduction
HIV infection is a global pandemic and the population
is growing due to successful treatment with highly active
antiretroviral therapy (HAART) [1]. Although rates of HIV
have been reduced in the United States among most groups
as a result of successful public health eﬀorts (e.g., condom
accessibility, education programs, media campaigns), sexual
risk behavior and subsequent acquisition and/or spread of
HIV and other sexually transmitted infections are still of
concern among men who have sex with men as well as
drug using populations [1]. Thus, it is evident that, despite
research and eﬀorts to understand and curb sexual risk
behavior within these vulnerable populations, additional
work employing novel approaches are needed.
Sexual risk behaviors can be viewed as a composite of
numerous behaviors that collectively make-up a complex
behavioral phenotype. As with most complex phenotypes,
sexual risk behavior is heterogeneous and several factors
contribute to the variance that can be observed from one
individual to another. To date, a majority of work examining
risk factors for sexual risk behavior phenotypes have primar-
ily focused on psychosocial factors (reviewed in [2]) and/or
other complex/heterogeneous behavioral phenotypes such
as substance use behaviors [3, 4] as indicators for current
or future sexual risk behavior. Ultimately these indicators,
upon suﬃcient replication, become candidates for public
health interventions that aim to prevent and reduce sexual
risk behaviors. However, the trouble with many of these
candidates is that they are too proximal to sexual risk behav-
iors and often cooccur, making it diﬃcult to disentangle
temporal precedence and ultimately limit prevention eﬀorts.
One relatively novel approach is to examine intermediate
phenotypes or endophenotypes [5]s u c ha sn e u r o c o g n i t i v e2 Interdisciplinary Perspectives on Infectious Diseases
factors as well as biological (i.e., genetic) factors. These
factors are more distal to the onset of sexual risk behavior
and thus are potentially more advantageous candidates for
identifying vulnerable individuals and informing prevention
eﬀorts for sexual risk behavior.
Studies in literature examining neurocognitive and bio-
logical factors as indicators for sexual risk behaviors are
limited. In fact, only two studies to date have examined
neurocognitive factors [6, 7] and none to our knowledge
have examined biological factors as potential indicators.
Although this paucity of research is surprising given
previous work linking both neurocognitive [8–10]a n d
genetic [11–13] indicators to other health related behaviors,
research has established the dopminergic system as a com-
mon link between neurocognitive functioning and sexual
behavior.
The dopminergic system has been shown to be involved
in sexual arousal, motivation and the subsequent rewarding
eﬀect of sexual behavior (for detailed review see [14]).
Furthermore, DA in the human brain, speciﬁcally in the
prefrontal cortex (PFC), has been shown to be necessary
for proper cognitive functioning to occur and high or low
levels of DA in this brain region are known to contribute to
individual cognitive diﬀerences in humans [15, 16]. The PFC
is of particular importance when examining risk behavior in
that executive functions such as decision-making, planning,
self-monitoring as well as behavior initiation, organization,
and inhibition are largely dependent on PFC integrity
[17]. Impairment in executive functioning may result in
diﬃculties in assessing relationships between a person’s
current behavior and future outcomes; thereby resulting
in choices and/or responses on the premise of immediate
rewards (e.g., pleasure, social acceptance) versus long-
term consequences (e.g., viral infections) and an ultimate
potentialincreaseinthelikelihoodforparticipationinsexual
risk behaviors (e.g., unprotected sex, multiple partners)
[7, 18]. Thus, mechanisms responsible for maintaining a
dopaminebalancewithinthebrainandinparticularthePFC
would appear to be good biological candidates for further
exploration of an association between executive dysfunction
and sexual risk behavior.
One such candidate is catechol-O-methyltransferease
(COMT) which is a mammalian enzyme involved in the
metabolic degradation of released dopamine, particularly
in the PFC [19]. Of particular interest to this study is a
common polymorphism involving a Val to Met substitution
at codon 158. The Val allele of the COMT Val158Met
polymorphism is 40% more enzymatically active than the
Met allele [20] .T h u s ,c a r r i e r so ft h eM e ta l l e l em e t a b o l i z e
dopamine at a less eﬃcient rate, resulting in higher levels
of dopamine in the synapse and ultimately an escalation
in dopamine receptor activation. This diﬀerentiation of
dopamine receptor activity dependent on COMT genotype
has led to several investigations into the relationship between
COMT and executive dysfunction in which the Val allele
has been putatively linked to poor performance on executive
functioning tasks [21]. However, to our knowledge no work
has examined the relationship between COMT and sexual
risk behavior; albeit studies of similar behaviors such as
novelty seeking [22–24], reward dependence [22], as well
as aﬀective arousal and regulation [25] have demonstrated
signiﬁcant relationships.
Given the aforementioned paucity of research in the
current literature addressing the contribution of genetic
and neurocognitive factors on sexual risk behavior, the
primary aim of this study was to examine the main eﬀects
of executive functioning as well as the main eﬀects of the
COMT Val158Met polymorphism on sexual risk behavior
among a ethnically diverse population of men with and
without METH dependence and/or HIV infection. Within
this aim, we hypothesized that the highly active COMT
Val/Valgenotypeanditsputativelyassociateddeﬁcitsinexec-
utive functioning would be independently associated with
sexual risk behaviors. In addition, as a result of previously
mentioned research that has demonstrated an association
between COMT genotype and executive functioning we also
explored the potential interaction eﬀects of COMT and
executive dysfunction on sexual risk behavior.
2. Methods
2.1. Participants. Participants were volunteers evaluated at
the HIV Neurobehavioral Research Center (HNRC) at
the University of California in San Diego as part of a
cohort study focused on central nervous system eﬀects
of HIV and methamphetamine. The current study com-
prised 192 sexually active non-monogamous men with
and without methamphetamine dependence (METH+/−)
and/or HIV infection (HIV+/−). Men were classiﬁed as non-
monogamous if they stated they had “no current partner”
at time of assessment. Monogamous men were excluded
because unsafe sexual behavior within a monogamous rela-
tionship is less risky than in non-monogamous relationships
[26].
All participants underwent a comprehensive characteri-
zation procedure that included collection of demographic,
neuromedical, psychiatric as well as neuropsychiatric infor-
mation. HIV serological status was determined by enzyme
linked immunosorbent assays (ELISA) plus a conﬁrma-
tory test. Lifetime METH dependence was determined by
the Structured Clinical Interview for the Diagnostic and
Statistical Manual of Mental Disorders Version IV (SCID-
IV). However, participants were not actively using other
substances, with the exception of cannabis and alcohol.
Potential participants were excluded if they met lifetime
dependence criteria for other drugs, unless the dependence
wasjudgedtoberemote(morethan5yearsago)andepisodic
in nature by a doctoral level clinician. Alcohol dependence
within the last year was also an exclusion criterion. All
participants were seronegative for hepatitis C infection.
Additionalinformationforeachparticipantwascollected
as it relates to current depressed mood as well as lifetime
diagnosis of Major Depression Disorder (MDD) and/or
Bipolar Disorder I or II. Current depressed mood was
assessed utilizing the Beck Depression Inventory-I (BDI-I)
[27] and MDD and Bipolar Disorder were ascertained using
the SCID-IV. Information was also collected to determine
lifetime dependence on sedatives, cannabis, opioids, cocaine,Interdisciplinary Perspectives on Infectious Diseases 3
hallucinogens, and alcohol, using the SCID-IV. For METH+
participants, additional information was collected regarding
a g ea tﬁ r s tu s e ,y e a r so fu s e ,a n dd a y ss i n c el a s tu s eo fM E T H ;
whereas for HIV+ participants, HIV RNA plasma copies
was ascertained as part of a larger neuromedical evaluation.
All participants gave written consent prior to enrollment
and all procedures were approved by the Human Research
Protection Program of the University of California, San
Diego and San Diego State University.
2.2. Executive Functioning. Executive functioning was deter-
mined as part of a larger comprehensive battery of tests
covering seven ability domains (Learning, Memory, Atten-
tion/Working Memory, Verbal Fluency, Processing Speed,
Abstraction/Problem Solving, and Motor Speed). The exec-
utive functioning domain deﬁcit score, of particular focus
in this study, was made up of (1) perseverative responses
on the Wisconsin Card Sorting Test [28]; (2) errors on the
Halstead Category Test [29] ,w h i c hm e a s u r e sa b s t r a c t i o n
and cognitive ﬂexibility; and (3) time to complete the Trail
Making Test part B (Trails B) [30], reﬂecting ability to
switch and maintain attention between ongoing sequences.
Raw scores for each of these component tests were con-
verted to demographically-adjusted T-scores (M = 50,
SD=10), including adjustments for age, education, gender,
and ethnicity as available for each test. The demographically-
adjusted T-scores for each test were then converted into
deﬁcit scores, which reﬂect degree of impairment by setting
performances within the normal range at zero with a range
from 0 (T-score > 39; no impairment) to 5 (T-score <
20; severe impairment). Finally, the individual deﬁcit scores
were averaged to derive the domain deﬁcit score, which
reﬂects the severity of executive functioning deﬁcit. Previous
work has demonstrated that deﬁcit scores achieve good
diagnostic agreement with classiﬁcations made by blind
clinical ratings [31, 32]. All neurocognitive testing and
scoring was performed by trained psychometrists blinded to
participants’ genotypes.
2.3. Sexual Risk Behavior. Sexual risk behavior was assessed
through an HNRC-developed self-report measure covering
the preceding year. Information was gathered with regard
to age at ﬁrst intercourse as well as number of diﬀerent
sex partners. Age at time of ﬁrst intercourse was coded in
years for both male and female partners. However, when two
diﬀerent ages were given for ﬁrst intercourse, the younger of
the two ages was used. In addition, participants were asked
to indicate the percentage of time that they used a condom as
well as engaged in oral, vaginal, anal (receptive & insertive)
and/or intoxicated sex. Responses were recorded on a 6-
item, Likert-type scale with a value of 0=0%, 1=1%–5%,
2=6%–25%, 3=26%–50%, 4=51%–75% and 5=76%–
100%.
2.4. DNA Extraction and Genotyping. DNA was extracted
fromperipheralbloodmononuclearcellsstored(threetoﬁve
years) at −70◦C using the QIAamp DNA Mini kit (Qiagen,
Valencia, CA; Catalog #51185). The COMT Val158Met
polymorphism (rs4680) was assayed along with eight other
SNPs as part of a concurrent genetic association project
at the HNRC. A multiplex PCR technique designed using
SequenomSpectroDESIGNERsoftware(version3.0.0.3) was
employed by inputting a sequence containing 100bp of
ﬂanking sequence on either side of the COMT Val158Met
polymorphism. The SNP was then grouped into multiplexes
so that the extended product would not overlap in mass
with any other oligonucleotide present in the reaction mix,
and where no primer-primer, primer-product, or non-
speciﬁc interactions would occur. The PCR was carried
out in 384-well reaction plates in a volume of 5μl using
10ng genomic or whole-genome ampliﬁed (WGA) DNA. All
subsequent steps, up until the reaction, were spotted onto
the SpectroCHIP and carried out in the same reaction plate.
After PCR, any unincorporated dNTPs from the PCR were
removedfromthereactionbydigestionwithShrimpalkaline
phosphatase. dNTPs were removed so that they could not
play any role in the extension of the oligonucleotide at the
SNP site. The extension reaction was then carried out in the
presence of the extension oligonucleotide and a termination
mix containing mass-modiﬁed dideoxynucleotides which
extended the oligonucleotide over the SNP site with one
base. Before spotting onto the SpectroCHIP, the reaction
was cleaned by incubation with a cation-exchange resin
which removed any salts present. The extension product
was then spotted onto a 384-well spectroCHIP before
being ﬂown in the MALDI-TOF mass spectrometer. Data
were collected, in real time, using SpectroTYPER Ana-
lyzer 3.3.0.15, SpectraAQUIRE 3.3.1.1 and SpectroCALLER
3.3.0.14 (Sequenom) algorithms. All genotyping was per-
formed by an accredited commercial laboratory (Harvard
Medical School-Partners Healthcare Center for Genetics and
Genomics, Cambridge, MA CLIA no. 22D1005307).
2.5. Statistical Analysis. All statistical tests and procedures
were conducted using SPSS 10.0 (SPSS, 2000). Univariate
comparisons across the three COMT genotypes (i.e., Val/Val,
Val/Met, Met/Met) were performed using one-way analysis
of variance (ANOVA) for continuous and chi-squared tests
for categorical variables. In cases, where data violated
normality assumptions medians were calculated and non-
parametrictests(i.e.,Kruskal-Wallis)performed.Toexamine
the main and explore the interaction eﬀects of executive
functioning and COMT on sexual risk behaviors, hierarchi-
cal multiple linear regressions in accord with Barron and
Kenny’s approach [33] were conducted for each of the seven
sexual risk behaviors (see Section 2.3) under study. Prior
to running each analysis, the executive functioning variable
was centered and the COMT genotype contrast coded to
reduce problems resulting from multicollinearity (Kraemer
andBlasey,2004).Inaddition,interactiontermswerecreated
by multiplying COMT genotype by the centered executive
functioning variable. Next, multiple linear regressions were
used to examine potential confounders based on univariate
genotype comparisons described above. These confounders
included: ethnicity, METH status, HIV status and age at ﬁrst
intercourse. We also included BDI scores based on inclusion
of this measure in recent work testing a similar hypothesis4 Interdisciplinary Perspectives on Infectious Diseases
[7].ResultsshowedthatMETHstatus,HIVstatus,andageat
ﬁrst intercourse accounted for a signiﬁcant unique variance
for all sexual behaviors under investigation (R2 range:
0.06–0.39, Ps <. 02). Thus to control for these potential
confounding eﬀects, the residuals derived from each of
the sexual behavior models were used as the dependent
variables for all subsequent regression models. The centered
executive functioning variable and COMT genotype as well
as the new interaction term were then entered as indepen-
dent variables into seven individual hierarchical multiple
regression models using the residuals described above as
the dependent variable. For models in which a signiﬁcant
interaction was observed, a ﬁnal round of regressions were
conducted stratiﬁed by COMT genotype to determine the
nature of the interaction between executive functioning and
COMT on the particular sexual risk behavior. Due to the
exploratory nature of the interaction analysiswe selected a
relaxed alpha threshold alpha < . 1 0t or e d u c eT y p eI Ie r r o r s ,
albeit the traditional alpha threshold of .05 was used for all
other analyses.
3. Results
3.1. Participant Characteristics. Characteristics of the full
sample by each of the three COMT genotypes are summa-
rized in Table 1. All three genotype groups were comparable
in age, education, sexual behavior, executive functioning,
as well as psychiatric and substance dependence histories.
However, Val/Val carriers were signiﬁcantly more likely to
identify as African-American (χ2 = 17.67, P =.001), report
an earlier age of ﬁrst intercourse (F(2,189) = 3.51, P =.032),
and be seropositive for HIV (χ2 = 6.57, P =.038). Whereas,
Met-carriers (i.e., Met/Met or Val/Met) were signiﬁcantly
more likely to identify as Caucasian (χ2 = 14.32, P =.001).
Additionally, among METH+ participants Val/Val carriers
reported signiﬁcantly greater total years of METH use
(F(2,87) =3.12, P = .050) compared to their Met-carrying
counterparts.
3.2. Main Eﬀects of Executive Functioning and COMT.
Table 2 provides standardized multiple linear regression
coeﬃcient estimates for main and interaction eﬀects of
executive functioning and COMT genotype for each of
the seven sexual risk behaviors adjusting for METH status,
HIV status, and age at ﬁrst intercourse. A signiﬁcant
main eﬀect for the executive functioning domain deﬁcit
score was observed for number of partners (β =0.21,
P =.005). Additionally, results from the individual executive
functioning tests showed a signiﬁcant main eﬀect for T-
scores on the Wisconsin Card Sort and Halstead Category
tests in adjusted models of oral sex (β =0.20, P =.009)
and condom use (β =− 0.16, P =.030), respectively. Main
eﬀects were not observed for COMT genotype in any of the
regression models.
3.3. Interaction Eﬀects of Executive Functioning and COMT.
Applying an exploratory cut-oﬀ of P<. 10, signiﬁcant
interactions between the executive functioning domain
deﬁcit score and COMT were observed for number of sexual
partners (β = 0.50, P = .038), insertive anal sex (β = 0.50,
P = .046), and receptive anal sex (β = 0.50, P = .081)
(Table 2). Subsequent stratiﬁed analysis by COMT genotype,
revealed that among carriers of the Met/Met (β = 0.52,
P = .001) and to a lesser extent Val/Met (β = 0.20, P = .048)
genotype, increases in the executive functioning domain
deﬁcit score was signiﬁcantly associated with increases in the
number of sexual partners in the past 12 months. Stratiﬁed
analysis for insertive and receptive anal sex revealed similar
results. Among Met/Met and Val/Met carriers, an increase
in executive deﬁcit scores were associated with an increased
frequency of insertive (Met/Met: β = 0.18; Val/Met: β =
0.11) and receptive (Met/Met: β = 0.13; Val/Met: β =
0.11) anal sex in the past 12 months, albeit not statistically
signiﬁcant.
Results of regression analyses to examine interactions
between each of the three individual executive functioning
tests and COMT genotype are also shown in Table 2.F o r
the Wisconsin Card Sort Test no interactions were observed.
However, for Trails B, signiﬁcant interactions with COMT
were observed for insertive (β =− 0.99, P = .015) and
receptive (β =− 0.75, P = .066) anal sex, as well as oral
sex (β =− 0.68, P = .096). Stratiﬁed regression analysis
showed that among carriers of the Met/Met genotype, poor
performance on Trails B (i.e., low T-scores) was signiﬁcantly
associated with an increased frequency of insertive (β =
−0.38, P = .028) but not receptive (β =− 0.22, P =
.225) anal sex. Interestingly, among carriers of the Val/Val
genotype, T-scores on Trails B had a signiﬁcant positive
association with oral sex (β = 0.35, P = .013). Finally, for
the Halstead Category Test, a single interaction with COMT
was observed for condom use (β =− 1.13, P = .006). Among
carriers of the Met/Met (β =− 0.49, P = .004) and to
a lesser extent Val/Met (β =− 0.19, P = .064) genotype,
Halstead Category Test T-scores were negatively associated
with condom use.
4. Discussion
To our knowledge this study is the ﬁrst to examine main
eﬀects as well as explore the interaction eﬀects of COMT
genotype and executive functioning on sexual risk behavior.
Our main ﬁndings suggest signiﬁcant executive dysfunction
main eﬀe c t sf o rn u m b e ro fs e x u a lp a r t n e r sa sw e l la s
frequency of oral sex and condom use. In addition, results
of our exploratory interaction analyses provide evidence
that COMT genotype and executive dysfunction interact in
models of number of sexual partners, condom use, insertive
and receptive anal sex, as well as oral sex. Stratiﬁed analyses
further suggest that the strength of these associations is
dependent on the number of Met alleles the individual was
carrying, with the exception of oral sex in which Val/Val was
the informative genotype.
Our signiﬁcant executive dysfunction main eﬀects for
sexual risk behaviors are discordant with the only other
study, to our knowledge, that has examined the association
between executive dysfunction and sexual risk behavior [7].
In that study, no association was found between executiveInterdisciplinary Perspectives on Infectious Diseases 5
Table 1: Characteristics of full sample by COMT genotype.
COMT genotype
Full sample Val/Val Val/Met Met/Met
(n =192) (n =54) (n =103) (n =35)
Age (years) M (sd) 37 (9) 35 (9) 38 (9) 39 (11)
Education (years) M (sd) 13 (2) 13 (2) 13 (2) 14 (2)
WRAT4 M (sd) 100 (12) 99 (11) 100 (12) 104 (11)
Ethnicity (row %)
Caucasian 71 52 78 83 v/v < v/m, m/m∗∗
African-American 15 32 7 11 v/v > v/m, m/m∗∗
Hispanic 14 17 16 6
Executive Functioning Battery
Wisconsin card sort test T (sd) 45 (14) 47 (16) 44 (13) 46 (13)
Trials part B T (sd) 49 (11) 51 (12) 47 (10) 52 (11)
Halstead category Test T (sd) 46 (10) 47 (10) 44 (10) 47 (9)
Domain deﬁcit score M (sd) .55 (.69) .56 (.68) .62 (.74) .35 (.47)
Executive impairment (%) 45 46 50 31
Sexual Characteristics/Behavior
Age at ﬁrst intercourse M (sd) 15 (4) 14 (4) 16 (4) 17 (4) v/v < m/m∗
Sexual preference (% heterosexual) 33 35 31 38
Number partners in past 12mo Median (IQR) 3 (1,10) 4 (1, 11) 3 (1, 10) 2 (1, 5)
Condom use (>0% in past 12mo) 72 74 71 70
Insertive anal (>0% in past 12mo) 62 60 67 52
Receptive anal (>0% in past 12mo) 58 60 62 46
Oral sex (>0% in past 12mo) 93 94 93 94
Intoxicated sex (>0% in past 12mo) 64 63 66 61
Vaginal sex (>0% in past 12mo) 37 35 35 44
DSM-IV Psychiatric Disorder (% lifetime)
Major depression 36 36 35 40
Bipolar I or II 483 3
Beck depression inventory M (sd) 12 (9) 11 (8) 13 (10) 10 (9)
DSM-IV Substance Dependence (% lifetime)
Sedative 000 0
Cannabis 99 1 1 6
Opioid 000 0
Cocaine 775 1 4
Hallucinogen 000 0
Alcohol 17 15 20 14
Methamphetamine Parameters
Methamphetamine dependent (%) 47 37 52 49
Age at ﬁrst METH use, yrs M (sd) 24 (9) 23 (9) 25 (8) 27 (10)
T o t a lM E T Hu s e ,y r sM (sd) 11 (6) 13 (7) 11 (6) 8 (4) v/v > m/m∗
Last use of METH, days Median (IQR) 91 (36, 274) 122 (45, 731) 91 (32, 236) 91 (30, 244)
HIV Parameters
HIV seropositive (%) 56 70 51 49 v/v > v/m, m/m∗
HIV RNA, plasma (log copies/mL) M (sd) 2.1 (1.9) 2.4 (1.7) 2.0 (2.0) 1.7 (1.9)6 Interdisciplinary Perspectives on Infectious Diseases
Table 2: Multivariate linear regression coeﬃcients for main, interaction, and stratiﬁed eﬀects of executive functioning and COMT in seven
sexual risk behavior models.
Standardized Beta(a)
Main Eﬀect Interaction Straitﬁed
(b)
EF measure EF COMT EF × COMT Val/Val Val/Met Met/Met
Sexual Risk Behavior Model (n =192) (n =192) (n=192) (n=54) (n=103) (n=35)
Domain Deﬁcit Score
(1) Partners (# past 12 mo) 0.21∗∗ 0.10 0.50∗∗ 0.03 0.20∗∗ 0.52∗∗∗
(2) Condom use (% past 12 mo) 0.03 0.13 0.24 — — —
(3) Insertive anal (% past 12 mo) 0.06 0.07 0.50∗∗ −0.18 0.11 0.18
(4) Receptive anal (% past 12 mo) 0.05 0.05 0.44∗ −0.17 0.11 0.13
(5) Oral sex (% past 12 mo) −0.10 0.07 0.40 — — —
(6) Intoxicated sex (% past 12 mo) 0.07 −0.06 0.08 — — —
(7) Vaginal sex (% past 12 mo) −0.03 −0.04 −0.28 — — —
Wisconsin Card Sort Test (T-score)
(1) Partners (# past 12 mo) −0.09 0.08 −0.18 — — —
(2) Condom use (% past 12 mo) −0.10 0.12 −0.25 — — —
(3) Insertive anal (% past 12 mo) 0.01 0.07 −0.31 — — —
(4) Receptive anal (% past 12 mo) −0.02 0.04 −0.38 — — —
(5) Oral sex (% past 12 mo) 0.20∗∗ 0.09 0.13 — — —
(6) Intoxicated sex (% past 12 mo) −0.04 −0.07 0.32 — — —
(7) Vaginal sex (% past 12 mo) 0.04 −0.04 −0.04 — — —
T r a i l sB( T - s c o r e )
(1) Partners (# past 12 mo) −0.01 0.08 −0.54 — — —
(2) Condom use (% past 12 mo) −0.07 0.11 0.03 — — —
(3) Insertive anal (% past 12 mo) −0.06 0.06 −0.99∗∗ 0.18 −0.03 –0.38∗∗
(4) Receptive anal (% past 12 mo) −0.04 0.03 −0.75∗ 0.17 −0.06 −0.22
(5) Oral sex (% past 12 mo) 0.10 0.06 −0.68∗ 0.35∗∗ 0.01 0.01
(6) Intoxicated sex (% past 12 mo) −0.11 −0.07 0.13 — — —
(7) Vaginal sex (% past 12 mo) 0.07 −0.04 0.37 — — —
Halstead Category Test (T-score)
(1) Partners (# past 12 mo) −0.11 0.08 −0.16 — — —
(2) Condom use (% past 12 mo) −0.16∗∗ 0.11 −1.13∗∗ 0.08 –0.19∗ –0.49∗∗∗
(3) Insertive anal (% past 12 mo) 0.01 0.05 −0.22 — — —
(4) Receptive anal (% past 12 mo) −0.01 0.03 −0.59 — — —
(5) Oral sex (% past 12 mo) 0.06 0.06 −0.50 — — —
(6) Intoxicated sex (% past 12 mo) −0.04 −0.06 −0.44 — — —
(7) Vaginal sex (% past 12 mo) −0.05 −0.04 0.25 — — —
(a)all regression models adjusted for METH status, HIV status, age at ﬁrst intercourse.
(b)stratiﬁed analysis of EF eﬀects by genotype was conducted if a signiﬁcant (P<. 10) interaction was observed.
EF: executive functioning; COMT: catechol-O-methyltransferease (0 = Val/Val; 1 = Val/Met; 2 = Met/Met)
∗P<. 10; ∗∗P<. 05, ∗∗∗P<. 005.
dysfunction and sexual risk behavior among an African-
Americansampleofmenandwomenpoly-substanceabusers
with and without HIV infection. However, three major
methodological diﬀerences may explain our discordant
ﬁndings. First, Gonzalez et al. [7] estimated sexual risk
behavior in the past 6 months compared to our window of
12 months and also utilized a composite score rather than
individual sexual risk behaviors as their dependent variable.
Second, executive dysfunction was assessed using the Iowa
Gambling Task, delayed non-matching to sample paradigm,
and Stroop task-reaction time version which, respectively,
measure decision-making, working memory, and response
inhibition. Although these tests are well justiﬁed, other
components of executive functioning such as perseveration,
cognitive sequencing, and concept formation which were
assessed in the current study, were not examined. ThirdInterdisciplinary Perspectives on Infectious Diseases 7
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Figure 1: A theoretical model illustrating the interaction eﬀect
of a single genotype (i.e., COMT Val158Met polymorphism) and
endophenotype (i.e., executive functioning domain deﬁcit) on a
behavioral phenotype (i.e., number of sexual partners). Among
carriers of the COMT Met/Met and to a lesser extent the Val/Met
genotype the association between executive functioning deﬁcit and
number of sexual partners is signiﬁcantly stronger than among
carriers of the Val/Val genotype. ∗P<. 05; ∗∗P<. 01.
and ﬁnally, regression models were adjusted for sensation
seeking, a factor shown in previous research to be associated
with sexual risk behavior [34–37]; however, in the current
study sensation seeking data was not available and was not
adjusted for. Thus, future work examining the association
between executive dysfunction and sexual risk behaviors are
warranted; particularly research utilizing larger samples with
diversemeasuresofexecutivefunctioningandmodelsadjust-
ing for sensation seeking and other personality covariates.
Novel to the current study, we demonstrated several
genotype (i.e., COMT) by endophenotype (i.e., executive
dysfunction) interactions for sexual risk behaviors. A relaxed
signiﬁcance criterion (P<. 10) produced signiﬁcant interac-
tions for number of sexual partners, condom use, insertive
and receptive anal sex, as well as oral sex. These interactions
collectively advocate for further investigation of genotype-
endophenotype interactions for sexual risk behavior. How-
ever, due to the exploratory nature of these interactions
our discussion will be conﬁned to interactions observed for
number of sexual partners, frequency of insertive anal sex
and condom use, as interactions observed in these models
met the traditional signiﬁcance criterion (P<. 05).
We observed both a main and interaction eﬀect for
number of sexual partners, albeit only within the model
including the composite executive functioning deﬁcit score.
In this model we found that among carriers of the Met allele
(i.e., Met/Met or Val/Met), a positive association between
executive functioning deﬁcit and number of sexual partners
was present. Thus, among Met allele carriers those with
greater deﬁcit scores reported greater number of sexual
partners; whereas among Val/Val carriers this association
was not signiﬁcant. Similar to results for number of sexual
partners, stratiﬁed analysis showed that among carriers of
the Met/Met but not Val/Met or Val/Val genotype an positive
association between executive dysfunction and frequency of
insertive anal sex was present, although only statistically
signiﬁcant for models including the Trails B test. Thus,
individuals with lower T-scores (i.e., greater impairment)
on Trails B reported greater frequency of insertive anal sex
only if they were carriers of the Met/Met genotype. Finally,
the strongest interaction observed was between COMT
and the Halstead Category Test for frequency of condom
use. Contrary to the expected association, results suggest a
negativeassociationamongcarriersoftheMet/Metgenotype
in which lower T-scores (i.e., greater impairment) on the
Category Test was associated with an increased frequency
of condom use. This unexpected ﬁnding may be a result
of several factors. First, the psychometric properties of the
questionnaire used to measure sexual risk behaviors in our
s t u d yh a v en o tb e e nr e p o r t e da n dt h u sm e a s u r e m e n te r r o r
may be inﬂuencing our reported associations. Although
there is no agreed upon “gold-standard” for measuring
sexual risk behavior, recommendations from a review of 56
sexual risk behavior measures in the literature have been
developed [38] and future studies should be encouraged to
adopt these measurement strategies to improve accuracy of
sexual risk behavior characterization. Second, recall deﬁcits
may result in sexual risk behavior reporting errors. This is
particularly a concern when measuring sexual risk behavior
retrospectively over large spans of time (i.e., 12 months)
as was done in the current study. Post-hoc analysis within
our sample showed no signiﬁcant diﬀerence in recall deﬁcit
by COMT genotype, albeit there did appear to be a trend
(F(2,189) = 2.89; P = .058) in which carriers of the Val/Val
genotype had greater deﬁcits than that of Val/Met and
Met/Met genotypes (data not shown). Thus, it is possible
that recall deﬁcits within the Val/Val group biased our
ﬁndings toward those in the Met/Met group and should be
interpreted with caution. Finally and most speculative, harm
reduction campaigns have long aimed to increase condom
use within both HIV-infected and METH using populations
and our ﬁnding may be an artifact of their success.
Collectively, these ﬁndings provide a preliminary model
of diﬀerential susceptibility to sexual risk behavior via
executive dysfunction, dependent on COMT genotype, par-
ticularly the Met/Met genotype (Figure 1). Although the role
of the Met/Met genotype is contrary to our hypothesis,
our ﬁndings, when placed in the context of previous
research are informative. Recent research has linked the
COMT Met/Met genotype to novelty seeking behavior in
healthy [39] and methamphetamine using [24] populations.
In addition, work by Gonzalez et al. [7]o ne x e c u t i v e
functioning and sexual risk behavior demonstrated that
sensation seeking was independently associated with sexual
risk, particularly among HIV-seropositive individuals. Thus,
it appears that individuals with the Met/Met genotype
m a yh a v eal o w e rt o l e r a n c ef o rm o n o t o n ya n dm a ys e e k
and participate in higher risk behaviors such as METH
use or unprotected sex. Furthermore, work by our group
and others [40] have suggested that possession of the Met
allele enhances executive functioning in healthy controls;8 Interdisciplinary Perspectives on Infectious Diseases
however, this neuroprotective eﬀect is signiﬁcantly reduced
among individuals exposed to methamphetamine. Thus, it
is probable that in our sample, of which approximately half
were methamphetamine dependent, the putative protective
eﬀect of the Met/Met genotype is diminished and propensity
to sexual risk behavior enhanced.
It is apparent that the associations between COMT,
executive dysfunction, and sexual risk behavior are highly
complex and context dependent. The current study provides
preliminary evidence of these complex relationships and
advocates for larger investigations that improve upon and
consider several of the limitations that have been presented.
Future work should also attempt to address independent
and interaction eﬀects of other putative polymorphisms
particularly those involved in dopamine synthesis (e.g.,
Tyrosine Hydroxylase), metabolism (e.g., Monoamine Oxi-
dase A), and reception (e.g., Dopamine Receptors D1-4).
In addition, future transdisciplinary work that combines
genetic and neurocognitive factors with psychosocial (e.g.,
trauma, stress) factors will provide valuable insights and
elucidate a clearer picture of sexual risk behavior. Com-
pletion of such work in combination with the current as
well as others previous work will further our understanding
of the genotypic and endophenotypic factors involved in
the phenotypic expression of sexual risk behaviors and
potentially assist with risk identiﬁcation, prevention, and
treatment eﬀorts in the future.
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